Summary of clinical and laboratory parameters in treatment naïve patients of CeD with and without liver dysfunctions
| Total treatment-naïve patients with CeD screened 146 | Patients without liver dysfunction (n=118) | Patients with liver dysfunction (n=26) |
| Age (mean, years) | 28.3±11.0 | 28.6±9.1 |
| No (sex) | 66 (male) | 16 (male) |
| Hb (mean, g/dL) | 10.5±2.5 | 10.3±2.3 |
| S.ALT (mean, IU/L) | 18.6±5.0 | 57.4±35.3 |
| S.bilirubin (mean, mg/dL) | 0.66±0.4 | 1.31.2 |
| S.albumin (g/dL) | 4.6±0.3 | 3.2±0.6 |
| S.anti-tTG Ab titre fold rise (serotiter in patients in respect to the pathological cut-off value of the diagnostic kit used) | 8.7 | 10.4 |
| LSM (mean±SD) | 4.5±4.1 | 8.7±3.8 |
ALT, alanine aminotransferase; CeD, coeliac disease; Hb, haemoglobin; LSM, liver stiffness measurement; tTG, tissue transglutaminase.